Ameritas Investment Partners, Inc. Pmv Pharmaceuticals, Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.01 - $8.93 $6,070 - $9,019	1,010 Added 36.57%	3,772 $23,000
Q2 2022 Aug 12, 2022	BUY	$9.23 - $22.43 $6,507 - $15,813	705 Added 34.27%	2,762 $39,000
Q2 2021 Aug 06, 2021	BUY	$28.01 - $36.01 $25,573 - $32,877	913 Added 79.81%	2,057 $70,000
Q4 2020 Feb 12, 2021	BUY	$31.86 - $61.51 $36,447 - $70,367	1,144 New	1,144 $70,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.